IL6 and COVID-19: In most studies, compared with healthy controls, COVID-19 patients had significantly higher levels of interleukin (IL)-2, IL-4, IL-6, IL-10, tumor necrosis factor (TNF)-α, and C-reactive protein (CRP) and lower lymphocyte counts.